DISCUSSION
Despite the high risk of osteoporotic fractures in olderpeople, there is little published evidence on treatment in this cohort. Studies have either included limited numbers or excluded older people due to strict entry criteria based on age and related factors. There is favourable published safety data for risedronate, zoledronic acid, strontium ranelate and teriparatide use in older people.